Skip to Content

Aarti Drugs Ltd - Stock Quote 524348

Rating as of

Morningstar's Aarti Drugs Ltd Stock Analysis

Valuation
Currency in INR
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Aarti Drugs Ltd's Company Profile

Business Description

Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise of Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of revenue from India.

Contact
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor
Mumbai, MH, 400 022, India
T +91 2224019025
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2022
Fiscal Year End Mar 31, 2022
Stock Type
Employees 1,620